Onexton Approval History
- FDA approved: Yes (First approved November 25th, 2014)
- Brand name: Onexton
- Generic name: benzoyl peroxide and clindamycin phosphate
- Dosage form: Gel
- Company: Valeant Pharmaceuticals International, Inc.
- Treatment for: Acne
Onexton (benzoyl peroxide and clindamycin phosphate) is an antimicrobial and lincosamide antibacterial combination for the once-daily topical treatment of acne vulgaris.
Development History and FDA Approval Process for Onexton
|Nov 25, 2014||Valeant Pharmaceuticals Announces FDA Approval of Onexton Gel for Acne Vulgaris|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.